TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹8,343 Cr | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr |
What is the latest Total Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹8,343 Cr |
| Mar2025 | ₹4,717 Cr |
| Mar2024 | ₹5,425 Cr |
| Mar2023 | ₹5,447 Cr |
| Mar2022 | ₹4,415 Cr |
How is Total Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,343 Cr | 76.87 | |
| Mar2025 | ₹4,717 Cr | -13.05 | |
| Mar2024 | ₹5,425 Cr | -0.40 | |
| Mar2023 | ₹5,447 Cr | 23.38 | |
| Mar2022 | ₹4,415 Cr | - | |
Compare Total Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹190,694.5 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| MANKIND PHARMA | ₹98,747.3 Cr | -1.1% | -7.2% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.8% |
-0.5% |
37.1% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses